Work Productivity Loss in Early Arthritis During the First 3 Years of Disease: A Study From a French National Multicenter Cohort

被引:7
作者
Dadoun, Sabrina [1 ,2 ]
Guillemin, Francis [3 ]
Lucier, Sandy [4 ]
Looten, Vincent [1 ,2 ]
Saraux, Alain [5 ]
Berenbaum, Francis [6 ]
Durand-Zaleski, Isabelle [4 ]
Chevreul, Karine [4 ]
Fautrel, Bruno [1 ,2 ]
机构
[1] Hop La Pitie Salpetriere, AP HP, Paris, France
[2] Univ Paris 06, Paris, France
[3] Nancy Univ Hosp, Vandoeuvre Les Nancy, Lorraine, France
[4] URC ECO, Paris, France
[5] CHU Brest, F-29285 Brest, France
[6] Ctr Hosp Univ St Antoine, Paris, France
关键词
EARLY RHEUMATOID-ARTHRITIS; SWEDISH TIRA PROJECT; INDIRECT MEDICAL COSTS; QUALITY-OF-LIFE; FIN-RACO TRIAL; SICK LEAVE; FOLLOW-UP; ANKYLOSING-SPONDYLITIS; DISABILITY; DIAGNOSIS;
D O I
10.1002/acr.22298
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Objective. To assess work productivity (WP) loss during the first 3 years of disease in a cohort of patients with early arthritis (EA) diagnosed between 2002 and 2005. Methods. The ESPOIR (Etude et Suivi des Polyarthrites Indifferenciees Recentes) cohort included 813 EA patients; we included those of working age at baseline in the present study. WP loss was assessed by 3 components: sick leave, permanent disability, and early retirement. The proportion of affected patients and the mean number of days off work were assessed for each component. WP costs were estimated and determinants of positive and extreme costs were assessed by logistic regression models. Results. Among the 664 patients included, 81.6% were in the workforce at baseline. During the first 3 years of disease, 45% reported at least 1 sick leave day and 11% reported permanent disability. Only a few patients (1%) reported early retirement. The mean number of days on sick leave due to EA decreased regularly from 44 to 13, whereas the mean number of days on permanent disability tripled from 10 to 33. The mean annual cost was (sic)1,333 (95% confidence interval (sic)1,075-1,620). Sick leave longer than 30 days due to EA before inclusion and a decrease in mental and physical scores of the Medical Outcomes Study Short Form 36 at inclusion were independent determinants of positive and extreme costs in multivariate models. Conclusion. WP loss is substantial in EA patients and is due to permanent disability before the third year of disease. Work absence and poor mental and physical health status at baseline are major determinants of WP costs.
引用
收藏
页码:1310 / 1318
页数:9
相关论文
共 54 条
[1]
2010 Rheumatoid Arthritis Classification Criteria An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative [J].
Aletaha, Daniel ;
Neogi, Tuhina ;
Silman, Alan J. ;
Funovits, Julia ;
Felson, David T. ;
Bingham, Clifton O., III ;
Birnbaum, Neal S. ;
Burmester, Gerd R. ;
Bykerk, Vivian P. ;
Cohen, Marc D. ;
Combe, Bernard ;
Costenbader, Karen H. ;
Dougados, Maxime ;
Emery, Paul ;
Ferraccioli, Gianfranco ;
Hazes, Johanna M. W. ;
Hobbs, Kathryn ;
Huizinga, Tom W. J. ;
Kavanaugh, Arthur ;
Kay, Jonathan ;
Kvien, Tore K. ;
Laing, Timothy ;
Mease, Philip ;
Menard, Henri A. ;
Moreland, Larry W. ;
Naden, Raymond L. ;
Pincus, Theodore ;
Smolen, Josef S. ;
Stanislawska-Biernat, Ewa ;
Symmons, Deborah ;
Tak, Paul P. ;
Upchurch, Katherine S. ;
Vencovsky, Jiri ;
Wolfe, Frederick ;
Hawker, Gillian .
ARTHRITIS AND RHEUMATISM, 2010, 62 (09) :2569-2581
[2]
Work disability and its economic effect on 55-64-year-old adults with rheumatoid arthritis [J].
Allaire, S ;
Wolfe, F ;
Niu, JB ;
Lavalley, M ;
Michaud, K .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2005, 53 (04) :603-608
[3]
Contemporary prevalence and incidence of work disability associated with rheumatoid arthritis in the US [J].
Allaire, Saralynn ;
Wolfe, Frederick ;
Niu, Jingbo ;
Lavalley, Michael P. .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (04) :474-480
[4]
The effect of etanercept on work productivity in patients with early active rheumatoid arthritis: results from the COMET study [J].
Anis, Aslam ;
Zhang, Wei ;
Emery, Paul ;
Sun, Huiying ;
Singh, Amitabh ;
Freundlich, Bruce ;
Sato, Reiko .
RHEUMATOLOGY, 2009, 48 (10) :1283-1289
[5]
THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[6]
Patients with rheumatoid arthritis treated with tumour necrosis factor antagonists increase their participation in the workforce: potential for significant long-term indirect cost gains (data from a population-based registry) [J].
Augustsson, J. ;
Neovius, M. ;
Cullinane-Carli, C. ;
Eksborg, S. ;
van Vollenhoven, R. F. .
ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (01) :126-131
[7]
Barber JA, 2000, STAT MED, V19, P3219, DOI 10.1002/1097-0258(20001215)19:23<3219::AID-SIM623>3.0.CO
[8]
2-P
[9]
Measuring Worker Productivity: Frameworks and Measures [J].
Beaton, Dorcas ;
Bombardier, Claire ;
Escorpizo, Reuben ;
Zhang, Wei ;
Lacaille, Diane ;
Boonen, Annelies ;
Osborne, Richard H. ;
Anis, Aslam H. ;
Strand, C. Vibeke ;
Tugwell, Peter S. .
JOURNAL OF RHEUMATOLOGY, 2009, 36 (09) :2100-2109
[10]
Effect of the Early Use of the Anti-Tumor Necrosis Factor Adalimumab on the Prevention of Job Loss in Patients With Early Rheumatoid Arthritis [J].
Bejarano, Victoria ;
Quinn, Mark ;
Conaghan, Philip G. ;
Reece, Richard ;
Keenan, Anne-Maree ;
Walker, David ;
Gough, Andrew ;
Green, Michael ;
McGonagle, Dennis ;
Adebajo, Ade ;
Jarrett, Stephen ;
Doherty, Sheelagh ;
Hordon, Lesley ;
Melsom, Richard ;
Unnebrink, Kristina ;
Kupper, Hartmut ;
Emery, Paul .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (10) :1467-1474